Advertisement

#GU20

Harry Nutsickle does GU20

Reporter’s Notebook: Financial Woes and Dodgy Statistics Cross All Cancers (GU20)

Genitourinary Cancers Symposium reaches beyond the latest prostate, bladder and kidney cancer treatments.

Male reproductive system

Zytiga Linked to Better Quality of Life in Men With Prostate Cancer

Men who took Zytiga had higher quality of life scores and less pain than those treated with chemotherapy.

New Targeted Therapy Shows Promise for Kidney Cancer

MK-6482 shrank tumors in 24% of people with advanced renal cell carcinoma.

T cells and dendritic cells

Provenge Prostate Cancer Vaccine Linked to Longer Survival

The personalized vaccine was associated with a 45% lower risk of death in a real-world study.

Padcev Combo Continues to Show Promise for Advanced Bladder Cancer

Updated study results show antibody-drug conjugate plus Keytruda shrinks tumors in 73% of patients.

Advertisement